Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Other Current Liabilities history
Currency unavailable · from the balance sheet
No Other Current Liabilities data reported for this period type.
Other Current Liabilities vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $54.45M USD | +160.1% | +59.2% | 7.7% | |
| Jun 2026 | $34M USD | -39.1% | +51.8% | 1.8% | |
| Mar 2026 | $6.98M USD | — | — | 2.4% | |
| Mar 2026 | $3.64M USD | -4.8% | -3.9% | 2.7% | |
| Mar 2026 | $1.23M USD | -62.3% | — | 0.7% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -21.9% | +51.8% | 2.4% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.